Ian Hodgson

Currently, working as Head of Clinical Operations for Mereo BioPharma, a small UK-based biopharma company specialising in rare diseases, Ian has approx. 20 years’ experience in clinical development. Working for small, medium, large pharma and CROs, including Takeda oncology, Shire, ICON, Sanofi in clinical science and operational roles he has a broad therapeutic and operations experience in early & late phase development which has supported successful registrations in US, EU and Japan. He has been successful in operationalising complex programs in orphan and specialty indications and has a PhD in Medical Microbiology from the University of Edinburgh and Queen Margaret University College.